Deucravacitinib (BMS-986165), CAS [[1609392-27-9]]

Produktübersicht

• Artikelname: Deucravacitinib (BMS-986165), CAS [[1609392-27-9]]
• Artikelnummer: AMO-M4138
• Hersteller Artikelnummer: M4138
• Alternativnummer: AMO-M4138-1MG,AMO-M4138-5MG,AMO-M4138-10MG,AMO-M4138-25MG
• Hersteller: Abmole Bioscience
• Kategorie: Biochemikalien
• Alternative Synonym: BMS986165

Produktbeschreibung

Deucravacitinib (BMS-986165) is a first-in-class, selective, orally bioavailable inhibitor of TYK2 transitions.Deucravacitinib selectively binds the TYK2 pseudokinase (JH2) structural domain with an IC50 of 1.0 nM and a Ki value of 0.02 nM. Deucravacitinib (BMS-986165) blocks receptor-mediated Tyk2 activation by stably regulating the JH2 structural domain. deucravacitinib also inhibits the IL-12/23 and type I IFN pathways. deucravacitinib may be used in psoriasis research.

Produkteigenschaften

• Molekulargewicht: 425.46
• Reinheit: 99.17%
• CAS Nummer: [1609392-27-9]
• Formel: C20H19D3N8O3
• Target-Kategorie: JAK